Sentry Investment Management LLC Has $1.44 Million Holdings in Iqvia Holdings Inc (IQV)

Sentry Investment Management LLC raised its position in Iqvia Holdings Inc (NYSE:IQV) by 16.1% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 11,077 shares of the medical research company’s stock after acquiring an additional 1,540 shares during the quarter. Sentry Investment Management LLC’s holdings in Iqvia were worth $1,437,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in IQV. Cutler Group LP increased its position in shares of Iqvia by 173.3% in the second quarter. Cutler Group LP now owns 1,100 shares of the medical research company’s stock valued at $109,000 after acquiring an additional 2,600 shares during the period. Townsend & Associates Inc purchased a new position in shares of Iqvia in the second quarter valued at about $117,000. Fort L.P. purchased a new position in shares of Iqvia in the second quarter valued at about $118,000. Hamilton Lane Advisors LLC purchased a new position in shares of Iqvia in the third quarter valued at about $121,000. Finally, Quad Cities Investment Group LLC purchased a new position in shares of Iqvia in the second quarter valued at about $140,000. Hedge funds and other institutional investors own 91.36% of the company’s stock.

In related news, Director John G. Danhakl sold 370,470 shares of the business’s stock in a transaction dated Wednesday, September 12th. The shares were sold at an average price of $124.83, for a total transaction of $46,245,770.10. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Kevin C. Knightly sold 9,216 shares of the business’s stock in a transaction dated Friday, September 7th. The stock was sold at an average price of $126.46, for a total transaction of $1,165,455.36. The disclosure for this sale can be found here. Insiders have sold 601,586 shares of company stock worth $75,510,422 in the last three months. 6.00% of the stock is currently owned by insiders.

NYSE:IQV opened at $124.17 on Friday. Iqvia Holdings Inc has a one year low of $91.57 and a one year high of $135.48. The company has a debt-to-equity ratio of 1.41, a quick ratio of 1.09 and a current ratio of 1.09. The stock has a market cap of $25.62 billion, a P/E ratio of 24.97, a price-to-earnings-growth ratio of 1.82 and a beta of 0.81.

Iqvia (NYSE:IQV) last posted its quarterly earnings data on Monday, October 22nd. The medical research company reported $1.42 EPS for the quarter, topping the consensus estimate of $1.39 by $0.03. Iqvia had a net margin of 12.29% and a return on equity of 13.69%. The business had revenue of $2.59 billion for the quarter, compared to analyst estimates of $2.58 billion. The company’s revenue was up 5.2% compared to the same quarter last year. Research analysts anticipate that Iqvia Holdings Inc will post 5.13 EPS for the current fiscal year.

IQV has been the topic of a number of research reports. Robert W. Baird lifted their target price on shares of Iqvia from $127.00 to $143.00 and gave the company an “outperform” rating in a research note on Wednesday, July 25th. UBS Group initiated coverage on shares of Iqvia in a research note on Tuesday, October 9th. They set a “buy” rating on the stock. Jefferies Financial Group reaffirmed a “hold” rating and set a $119.00 target price on shares of Iqvia in a research note on Friday, July 20th. Zacks Investment Research lowered shares of Iqvia from a “buy” rating to a “hold” rating in a research note on Thursday, October 25th. Finally, Barclays lifted their target price on shares of Iqvia from $130.00 to $140.00 and gave the company an “overweight” rating in a research note on Tuesday, October 23rd. Five equities research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the stock. The stock presently has an average rating of “Buy” and an average target price of $131.67.

ILLEGAL ACTIVITY WARNING: “Sentry Investment Management LLC Has $1.44 Million Holdings in Iqvia Holdings Inc (IQV)” was first reported by American Banking News and is owned by of American Banking News. If you are reading this report on another publication, it was stolen and reposted in violation of US and international copyright & trademark laws. The original version of this report can be viewed at https://www.americanbankingnews.com/2018/11/10/sentry-investment-management-llc-has-1-44-million-holdings-in-iqvia-holdings-inc-iqv.html.

Iqvia Profile

IQVIA Holdings Inc provides integrated information and technology-enabled healthcare services in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Commercial Solutions, Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offers a range of cloud-based applications and related implementation, real-world insights, and reference information services; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services.

See Also: Put Option

Institutional Ownership by Quarter for Iqvia (NYSE:IQV)

Receive News & Ratings for Iqvia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Iqvia and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply